Moreover, these dose-dependent effects on metastatic infiltration seem to be exclusive of the TLR4 signaling, since stimulation of other TLRs did not affect the infiltration of the breast cancer cells in our ex vivo model (Fig. 2A). The gene discussed is TLR4; the disease is breast carcinoma.